Biocon Limited has informed the Exchange regarding a press release dated May 16, 2024, titled " Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr; FY24 Revenue at Rs 15,621 Cr, Up 35%; EBITDA at Rs 4,164 Cr, Up 44%; Net Profit (before exceptional items) at Rs 1,030 Cr, Up 31%; Biosimilars Revenue in FY24 Crosses USD 1 Bn".